Antioxidants attenuate TBC1D24-TLDc-related epilepsy exercise-induced dystonia

Lesen Sie diesen Artikel auf Deutsch.

Takeaway

  • Mutations in the TBC/lysin motif domain/catalytic (TLDc) domain of TBC1D24 cause Rolandic-type focal motor epilepsy; the TBC1D24/Sky TLDc domain is a reactive oxygen species (ROS) sensor mediating synaptic vesicle trafficking rates that can result in movement disorders when dysfunctional.

Why this matters

  • These findings highlight a potential therapeutic strategy for TBC1D24-associated diseases, in which previously described lipid-altering strategies that target TBC dysfunction are combined with antioxidants which target TLDc mutant hypersensitivity to ROS.

Mochten Sie mehr lesen?

Möchten Sie mehr lesen?

Loggen Sie sich ein oder registrieren Sie sich, um Zugang zu allen Inhalten von Neurodiem zu erhalten.

Sie haben bereits einen Account? Einloggen

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.